From The Editor | March 3, 2014

FDA And Industry Experts Offer Guidance For DQSA Preparation

To access this content, please Register or Sign In.

By Trisha Gladd, editor, Pharmaceutical Online and Bioresearch Online
Follow Me On Twitter @pharmaonline and @bioresearchonline

Trisha Gladd

It’s been over three months since President Obama signed the Drug Quality and Security Act (DQSA) into law, and some of the industry is still unsure how to proceed with preparation for Title II, which outlines the plan for supply chain security. The first requirement stemming from the DQSA goes into effect on January 1st 2015. Under this section of the law, manufacturers, wholesalers, and re-packagers must be able to capture and provide the next owner in the supply chain an electronic or paper transaction history, information, and statement. From there, requirements will continue to roll out, and it’s imperative to know which ones affect your company.

In a recent discussion with Pharmaceutical Online, Ilisa Bernstein, Pharm.D, JD, Deputy Director of the U.S. FDA Office of Compliance in the Center for Drug Evaluation and Research (CDER), encouraged the industry to familiarize itself with the law and the requirements under it. “If you are a manufacturer, wholesaler, or packager, know what you need to do and by when it is stated in the law,” says Bernstein. “There are some things FDA will be providing guidance on as additional regulations under the law, but in the meantime, the stakeholders need to know what is coming and what they need to do.”

Newsletter Signup
Newsletter Signup